Market Growth Has Experienced a Change of 25.29% YoY in 2020
1h Free Analyst Time
The companion diagnostics market is forecasted to grow by USD 28.98 billion during 2023-2028, accelerating at a CAGR of 36.5% during the forecast period. The report on the companion diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising use of personalized medicine, increased industry collaborations, and growing investments in life sciences sector.
The companion diagnostics market is segmented as below:
By End-user
- Life science
- Health centers
- Others
By Indication
- Oncology
- Neurology
- Others
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the companion diagnostics market covers the following areas:
- Companion diagnostics market sizing
- Companion diagnostics market forecast
- Companion diagnostics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Indication
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global companion diagnostics market: Abbott Laboratories, Abnova Corp., Agilent Technologies Inc., Amoy Diagnostics Co. Ltd., ARUP Laboratories, Bayer AG, BioGenex Laboratories Inc., bioMerieux SA, F. Hoffmann La Roche Ltd., Guardant Health Inc., Illumina Inc., Invivoscribe Inc., Liquid Biotech USA Inc., Myriad Genetics Inc., NG Biotech, QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising occurrence of breast cancer."
According to the report, one of the major drivers for this market is the rising use of personalized medicine.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Abnova Corp.
- Agilent Technologies Inc.
- Amoy Diagnostics Co. Ltd.
- ARUP Laboratories
- Bayer AG
- BioGenex Laboratories Inc.
- bioMerieux SA
- F. Hoffmann La Roche Ltd.
- Guardant Health Inc.
- Illumina Inc.
- Invivoscribe Inc.
- Liquid Biotech USA Inc.
- Myriad Genetics Inc.
- NG Biotech
- QIAGEN NV
- Quest Diagnostics Inc.
- Siemens AG
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
